FDA approves updated prescribing information for Tradjenta® (linagliptin) tablets for add-on therapy to insulin in …

RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 17, 2012 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration …

Powered by WPeMatico